The timely Viral Vector Formulation and Process Development Summit Europe is the only definitive, end-to-end platform, uniting 60+ experts across up-and downstream process development, formulation, analytical development and regulatory disciplines from biopharma.
Across 3 days, hear from 18 viral vector pioneers working in cell and gene therapy and vaccine development, including Roche, VectorY, UCB, DiNAQOR and AviadoBio , to share their lessons learned and inspirations to overcome bottlenecks during scale-up and to reduce COGs.
Join thought leaders at this premium forum to increase your scale-up and manufacturing efficiency, deliver safe and cost-effective cures and treatments to larger patient populations.
Across 3 days, hear from 18 viral vector pioneers working in cell and gene therapy and vaccine development, including Roche, VectorY, UCB, DiNAQOR and AviadoBio , to share their lessons learned and inspirations to overcome bottlenecks during scale-up and to reduce COGs.
Join thought leaders at this premium forum to increase your scale-up and manufacturing efficiency, deliver safe and cost-effective cures and treatments to larger patient populations.
